Inhibitors of protein-protein interactions as potential drugs

被引:19
作者
Veselovsky, Alexander V. [1 ]
Archakov, Alexander I. [1 ]
机构
[1] Inst Biomed Chem, Moscow 119121, Russia
关键词
protein-protein interaction; inhibitors; target; dimerization; drug; flexibility; allosteric inhibition;
D O I
10.2174/157340907780058754
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Protein-protein interactions play a crucial role in numerous Vital cell functions. However protein-protein interactions are also responsible for pathological formation of protein aggregates, which determine the development of several diseases. The key role of protein-protein interactions for manifestation of numerous cell functions attracts much attention to protein complexes as perspective drug targets. So design or discovery of small molecules that would regulate protein-protein interactions represents great pharmacological interest. The recent progress in understanding of mechanism protein-protein interaction, including role of flexibility of protein-protein interfaces, thermodynamic of complex formation, discovery of small molecules modifying protein-protein interactions, the advantages and limitation of protein-protein inhibitors as potential drugs are discussed in this review.
引用
收藏
页码:51 / 58
页数:8
相关论文
共 118 条
[71]   Camptothecin and taxol: Historic achievements in natural products research [J].
Oberlies, NH ;
Kroll, DJ .
JOURNAL OF NATURAL PRODUCTS, 2004, 67 (02) :129-135
[72]   Recent advances in design, synthesis and biological activity of aminoalkylsulfonates and sulfonamidopeptides [J].
Obreza, A ;
Gobec, S .
CURRENT MEDICINAL CHEMISTRY, 2004, 11 (24) :3263-3278
[73]  
Ockey DA, 2002, EXPERT OPIN THER PAT, V12, P393
[74]   Toward proteomimetics:: Terphenyl derivatives as structural and functional mimics of extended regions of an α-helix [J].
Orner, BP ;
Ernst, JT ;
Hamilton, AD .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2001, 123 (22) :5382-5383
[75]   Emerging classes of protein-protein interaction inhibitors and new tools for their development [J].
Pagliaro, L ;
Felding, J ;
Audouze, K ;
Nielsen, SJ ;
Terry, RB ;
Krog-Jensen, C ;
Butcher, S .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2004, 8 (04) :442-449
[76]   Assembly of cell regulatory systems through protein interaction domains [J].
Pawson, T ;
Nash, P .
SCIENCE, 2003, 300 (5618) :445-452
[77]   Molecular modeling in the design of peptidomimetics and peptide surrogates [J].
Perez, JJ ;
Corcho, F ;
Llorens, O .
CURRENT MEDICINAL CHEMISTRY, 2002, 9 (24) :2209-2229
[78]   Interfacial inhibition of macromolecular interactions: nature's paradigm for drug discovery [J].
Pommier, Y ;
Cherfils, J .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2005, 26 (03) :138-145
[79]   Anchor residues in protein-protein interactions [J].
Rajamani, D ;
Thiel, S ;
Vajda, S ;
Camacho, CJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (31) :11287-11292
[80]   Consolidating the set of known human protein-protein interactions in preparation for large-scale mapping of the human interactome [J].
Ramani, AK ;
Bunescu, RC ;
Mooney, RJ ;
Marcotte, EM .
GENOME BIOLOGY, 2005, 6 (05)